Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

ASEM 文献综述

Official National Advisory Committee on Immunization document (2020) on “Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines”. Flucelvax® Quad is a mammalian cell culture-based, inactivated seasonal influenza vaccine that has recently been authorized for use in Canada in adults and children ≥9 years of age.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。